198 related articles for article (PubMed ID: 8854761)
21. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
[TBL] [Abstract][Full Text] [Related]
23. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
24. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
25. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
26. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Konno T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of carcinomatous effusion with oily anticancer agents dissolved in lipiodol].
Kimura M; Konno T; Oda T; Yamashita R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1579-82. PubMed ID: 2167635
[TBL] [Abstract][Full Text] [Related]
28. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma].
Nakaba H; Hashimoto T; Sunada S; Akamatsu D; Ito A; Teramoto S; Ohara S; Katayama S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687
[TBL] [Abstract][Full Text] [Related]
29. Chemoembolization for small hepatocellular carcinoma.
Nakamura H; Oi H
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():144-7. PubMed ID: 9210897
[No Abstract] [Full Text] [Related]
30. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of therapeutic effects of SMANCS (+TAE) and Non-SMANCS/LpTAE].
Nabeshima M; Ochi J; Hikita H; Nishikawa H; Ohara T; Torii A; Fujita S; Takeda J; Miura K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():99-104. PubMed ID: 9512696
[TBL] [Abstract][Full Text] [Related]
32. Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
Sohara N; Takagi H; Abe T; Hashimoto Y; Kojima A; Takahashi H; Nagamine T; Mori M
Support Care Cancer; 1999 Mar; 7(2):84-8. PubMed ID: 10089088
[TBL] [Abstract][Full Text] [Related]
33. [Segmental simultaneous arterio-portal chemoembolization of hepatocellular carcinoma].
Oi H
Nihon Rinsho; 1991 Aug; 49(8):1910-5. PubMed ID: 1664898
[No Abstract] [Full Text] [Related]
34. [Significance of lipiodol-CT in the evaluation of therapeutic effects of Lp-TAE for hepatocellular carcinoma--clinicopathologic study].
Jinno K; Tokuyama K; Yumoto Y; Wada T; Okamoto T; Kobashi H; Moriwaki S; Tanada M; Maeda H; Konno T
Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1660-71. PubMed ID: 2848080
[No Abstract] [Full Text] [Related]
35. Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
Phornphutkul K; Handagoon P; Sirivanichai C; Senarat S; Nakamura H
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1239-46. PubMed ID: 1325144
[No Abstract] [Full Text] [Related]
36. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
Inoue Y; Nakamura H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma.
Jinno K; Moriwaki S; Tanada M; Wada T; Mandai K; Okada Y
Cancer Chemother Pharmacol; 1992; 31 Suppl():S7-12. PubMed ID: 1333912
[TBL] [Abstract][Full Text] [Related]
38. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma].
Suzuki T; Kobayashi M; Nakamura T; Takahashi O; Imai K; Yamanaka H; Suzuki K; Konno T; Maeda H
Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2210-7. PubMed ID: 2833546
[No Abstract] [Full Text] [Related]
39. Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens.
Duvoux C; Cherqui D; Van Nhieu JT; Vavasseur D; Zafrani ES; Mathieu D; Fagniez PL; Dhumeaux D
Transplant Proc; 1994 Dec; 26(6):3572-3. PubMed ID: 7527981
[No Abstract] [Full Text] [Related]
40. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
